XXIZEXXSERXXCE XXMPAXX BV — Oxaliplatin Importer Profile
Pharmaceutical Importer · #10 buyer for Oxaliplatin · $430.8K import value · 10 shipments · THAILAND · DGFT Verified
XXIZEXXSERXXCE XXMPAXX BV is the #10 importer of Oxaliplatin from India with $430.8K in import value and 10 verified shipments. XXIZEXXSERXXCE XXMPAXX BV holds a 1.1% market share in Oxaliplatin imports based in THAILAND. The company sources from 1 verified supplier across 8 formulations shipped to 5 countries. Overall, XXIZEXXSERXXCE XXMPAXX BV imports 4 pharmaceutical products worth $2.0M across 2 therapeutic categories.
XXIZEXXSERXXCE XXMPAXX BV — Oxaliplatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Oxaliplatin to XXIZEXXSERXXCE XXMPAXX BV?
Verified from 10 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED | $430.8K | 10 | 100.0% |
XXIZEXXSERXXCE XXMPAXX BV sources Oxaliplatin from 1 verified Indian supplier based on 10 customs records. The primary supplier is ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED accounting for 100.0% of imports.
How Does XXIZEXXSERXXCE XXMPAXX BV Compare to Nearest Oxaliplatin Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | FRESENIUS KABI (THAILAND) LTD | THAILAND | $650.0K | 13 | $50.0K |
| 14 | C M C L | THAILAND | $620.1K | 27 | $23.0K |
| 10 | XXIZEXXSERXXCE XXMPAXX BV ★ | BELGIUM | $500.0K | 10 | $50.0K |
| 5 | OOOJODAS EXPOIM | RUSSIA | $450.0K | 9 | $50.0K |
| 15 | FRESENIUS KABI CHILE LTDA. | CHILE | $400.0K | 8 | $50.0K |
XXIZEXXSERXXCE XXMPAXX BV ranks #10 among 693 Oxaliplatin importers from India. Average shipment value of $50.0K compared to the market average of $29.9K. The closest competitors by value are FRESENIUS KABI (THAILAND) LTD and C M C L.
Where Does XXIZEXXSERXXCE XXMPAXX BV Import Oxaliplatin To?
Destination countries from 10 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| THAILAND | $146.7K | 3 | 34.0% |
| JAPAN | $100.0K | 2 | 23.2% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 23.2% |
| BELGIUM | $50.0K | 1 | 11.6% |
| SINGAPORE | $34.1K | 2 | 7.9% |
XXIZEXXSERXXCE XXMPAXX BV imports Oxaliplatin to 5 countries. The primary destination is THAILAND receiving 34.0% of shipments worth $146.7K.
What Oxaliplatin Formulations Does XXIZEXXSERXXCE XXMPAXX BV Import?
| Formulation | Value | Shipments |
|---|---|---|
| OXALIPLATIN INJ. 100MG US -F000207029 | $100.0K | 2 |
| OXALIPLATIN INJ. 100MG TH -F000041172 | $96.7K | 2 |
| OXALIPLATIN INJ.100MG-EG-F000057495 | $50.0K | 1 |
| OXALIPLATIN INJ. 50MG JP (H000015216 | $50.0K | 1 |
| OXALIPLATIN INJ. 200MG JP (H000015218) | $50.0K | 1 |
| OXALIPLATIN INJ. 50MG TH -F000041001 | $50.0K | 1 |
| OXALIPLATIN INJ. 50MG -SG-F000054120 | $19.1K | 1 |
| OXALIPLATIN INJ. 100MG -SG-F000054119 | $15.0K | 1 |
XXIZEXXSERXXCE XXMPAXX BV imports 8 distinct Oxaliplatin formulations from India. The top formulation is OXALIPLATIN INJ. 100MG US -F000207029 with 2 shipments worth $100.0K.
Who Are the Top Buyers of Oxaliplatin from India and How Much Does XXIZEXXSERXXCE XXMPAXX BV Import?
India exported $20.7M worth of Oxaliplatin through 3,081 shipments from 249 suppliers to 123 countries, serving 693 buyers globally. XXIZEXXSERXXCE XXMPAXX BV imports $430.8K of this total, accounting for 1.1% of India's Oxaliplatin exports with 10 shipments from THAILAND. This is verified from 10 customs shipment records covering 8 distinct formulations.
What Is the Average Order Value for XXIZEXXSERXXCE XXMPAXX BV's Oxaliplatin Imports?
XXIZEXXSERXXCE XXMPAXX BV's average Oxaliplatin order value is $43.1K per consignment, based on 10 shipments totaling $430.8K. XXIZEXXSERXXCE XXMPAXX BV is based in THAILAND and ranks #10 among all Oxaliplatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Oxaliplatin to XXIZEXXSERXXCE XXMPAXX BV?
XXIZEXXSERXXCE XXMPAXX BV sources Oxaliplatin from 1 verified Indian supplier: ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED ($430.8K, 100.0%). This is based on 10 customs records.
How Does XXIZEXXSERXXCE XXMPAXX BV Compare to Other Oxaliplatin Importers?
XXIZEXXSERXXCE XXMPAXX BV ranks #10 among 693 Oxaliplatin importers from India with a 1.1% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($10.0M), PHARMACIE CENTRALE DES HOPITAUX ($2.3M), YUSEN LOGISTICS BENELUX BELGIUM ($2.2M). XXIZEXXSERXXCE XXMPAXX BV processed 10 shipments from THAILAND.
What Other Advanced Oncology Products Does XXIZEXXSERXXCE XXMPAXX BV Import?
XXIZEXXSERXXCE XXMPAXX BV also imports these advanced oncology products. Each links to the detailed product page.
About XXIZEXXSERXXCE XXMPAXX BV
XXIZEXXSERXXCE XXMPAXX BV imports 4 products worth $2.0M. Beyond Oxaliplatin, top products include Gemcitabine, Cytarabine, Docetaxel. View the complete XXIZEXXSERXXCE XXMPAXX BV profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: XXIZEXXSERXXCE XXMPAXX BV matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as XXIZEXXSERXXCE XXMPAXX BV's capped import value divided by total capped export value for Oxaliplatin across all Indian exporters.
- 5.Verified Records: This page is backed by 10 individual customs records matching XXIZEXXSERXXCE XXMPAXX BV importing Oxaliplatin, covering 8 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 693+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oxaliplatin Import Data for XXIZEXXSERXXCE XXMPAXX BV
Access order-level details, pricing data, supplier connections, and competitive analysis for XXIZEXXSERXXCE XXMPAXX BV's Oxaliplatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
XXIZEXXSERXXCE XXMPAXX BV
Full Company Profile →
4 products · $2.0M total trade · 2 categories
XXIZEXXSERXXCE XXMPAXX BV × Oxaliplatin
Verified from customs records
Company Overview
Top Products by XXIZEXXSERXXCE XXMPAXX BV
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for XXIZEXXSERXXCE XXMPAXX BV.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oxaliplatin. For current order-level data, contact TransData Nexus.